Therefore, molecular strategies to inhibit those signaling pathway, together with the SDF-1/CXCR4 axis blockade, could lead to the development of novel more efficient anti-metastatic therapies to complement the conventional chemotherapy and radiotherapy in preventing the metastatic spread of neuroblastoma and other types of cancer. Here, CXCR4 is linked to neuroblastoma.